• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 637

Substance: Phosphatidylserine derived soy lecithin
Intended Use: Intended for use as a nutrient in dairy product analogs (imitation milk and soy milk), grain products (nutritional bars: breakfast, granola, and protein), milk products (flavored milk and milk drinks, excluding fluid milk, milk-based meal replacements, and yogurt), and processed fruits and fruit juices (fruit flavored drinks) at use levels ranging from 50 to 300 milligrams phosphatidylserine per serving.
Basis: Scientific procedures
Notifier: ECA Healthcare, Inc.
1017 North Building, 1839 Qixin Rd.,Shanghai, 201101, China
Date of filing: Mar 30, 2016
GRAS Notice (releasable information): 637 (in PDF) (2.2 MB)
Date of closure / FDA's Letter: Aug 4, 2016
At the notifier's request, FDA ceased to evaluate this notice
-
-